TD Waterhouse Canada’s Regenxbio RGNX Stock Holding History

TD Waterhouse Canada’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31K	Hold	100	–	–	﹤0.01%	2170
2026 Q1	$858	Buy	+100	New	+$1.05K	﹤0.01%	2111

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

TD Waterhouse Canada's RGNX Position: Q2 2026 in Review

TD Waterhouse Canada held its Regenxbio (RGNX) position steady in Q2 2026 at 100 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

TD Waterhouse Canada first reported a position in RGNX in Q1 2026 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

TD Waterhouse Canada held 100 shares of Regenxbio worth $1.31K as of Q2 2026.
TD Waterhouse Canada left its Regenxbio share count unchanged in Q2 2026.
Regenxbio made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2170 holding.
TD Waterhouse Canada first reported a position in Regenxbio in Q1 2026 and has held it in 2 quarters since.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.